vs
Side-by-side financial comparison of ADMA BIOLOGICS, INC. (ADMA) and H2O AMERICA (HTO). Click either name above to swap in a different company.
H2O AMERICA is the larger business by last-quarter revenue ($199.4M vs $139.2M, roughly 1.4× ADMA BIOLOGICS, INC.). ADMA BIOLOGICS, INC. runs the higher net margin — 35.5% vs 8.1%, a 27.3% gap on every dollar of revenue. On growth, ADMA BIOLOGICS, INC. posted the faster year-over-year revenue change (18.4% vs 1.5%). Over the past eight quarters, ADMA BIOLOGICS, INC.'s revenue compounded faster (30.4% CAGR vs 15.3%).
ADMA Biologics Inc. is a biopharmaceutical enterprise focused on the research, development, manufacturing and commercialization of specialty plasma-derived immunoglobulin therapies. It primarily operates in the United States, catering to patients with primary immunodeficiency and other immune-related disorders, healthcare providers and medical institutions across its core immune health therapeutic segment.
H2O Wireless is a United States-based prepaid cell phone service, that utilizes the AT&T network. It is a brand of the mobile virtual network operator (MVNO) Locus Telecommunications, a subsidiary of Telrite Holdings, Inc., since 2019. Locus was formerly a subsidiary of KDDI America corporation, starting in 2010. H2O Wireless is primarily advertised as a non-restrictive phone service for customers to bring or buy unlocked smartphones, although AT&T contract/locked phones may be accepted as well.
ADMA vs HTO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $139.2M | $199.4M |
| Net Profit | $49.4M | $16.2M |
| Gross Margin | 63.8% | — |
| Operating Margin | 45.1% | 16.6% |
| Net Margin | 35.5% | 8.1% |
| Revenue YoY | 18.4% | 1.5% |
| Net Profit YoY | -55.9% | -29.2% |
| EPS (diluted) | $0.20 | $0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $139.2M | $199.4M | ||
| Q3 25 | $134.2M | $243.5M | ||
| Q2 25 | $122.0M | $197.8M | ||
| Q1 25 | $114.8M | $164.9M | ||
| Q4 24 | $117.5M | $196.5M | ||
| Q3 24 | $119.8M | $216.7M | ||
| Q2 24 | $107.2M | $173.1M | ||
| Q1 24 | $81.9M | $150.0M |
| Q4 25 | $49.4M | $16.2M | ||
| Q3 25 | $36.4M | $45.1M | ||
| Q2 25 | $34.2M | $24.7M | ||
| Q1 25 | $26.9M | $16.6M | ||
| Q4 24 | $111.9M | $22.9M | ||
| Q3 24 | $35.9M | $38.7M | ||
| Q2 24 | $32.1M | $20.7M | ||
| Q1 24 | $17.8M | $11.7M |
| Q4 25 | 63.8% | — | ||
| Q3 25 | 56.3% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 53.2% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 49.8% | — | ||
| Q2 24 | 53.6% | — | ||
| Q1 24 | 47.8% | — |
| Q4 25 | 45.1% | 16.6% | ||
| Q3 25 | 38.0% | 26.5% | ||
| Q2 25 | 35.1% | 22.2% | ||
| Q1 25 | 30.4% | 21.8% | ||
| Q4 24 | 32.6% | 22.2% | ||
| Q3 24 | 33.1% | 26.9% | ||
| Q2 24 | 36.6% | 23.4% | ||
| Q1 24 | 26.7% | 18.6% |
| Q4 25 | 35.5% | 8.1% | ||
| Q3 25 | 27.1% | 18.5% | ||
| Q2 25 | 28.1% | 12.5% | ||
| Q1 25 | 23.4% | 10.0% | ||
| Q4 24 | 95.2% | 11.7% | ||
| Q3 24 | 30.0% | 17.8% | ||
| Q2 24 | 29.9% | 12.0% | ||
| Q1 24 | 21.7% | 7.8% |
| Q4 25 | $0.20 | $0.45 | ||
| Q3 25 | $0.15 | $1.27 | ||
| Q2 25 | $0.14 | $0.71 | ||
| Q1 25 | $0.11 | $0.49 | ||
| Q4 24 | $0.45 | $0.70 | ||
| Q3 24 | $0.15 | $1.17 | ||
| Q2 24 | $0.13 | $0.64 | ||
| Q1 24 | $0.08 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $87.6M | $20.7M |
| Total DebtLower is stronger | $72.1M | $1.9B |
| Stockholders' EquityBook value | $477.3M | $1.5B |
| Total Assets | $624.2M | $5.1B |
| Debt / EquityLower = less leverage | 0.15× | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6M | $20.7M | ||
| Q3 25 | $61.4M | $11.3M | ||
| Q2 25 | $90.3M | $19.8M | ||
| Q1 25 | $71.6M | $23.7M | ||
| Q4 24 | $103.1M | $11.1M | ||
| Q3 24 | $86.7M | $4.0M | ||
| Q2 24 | $88.2M | $22.8M | ||
| Q1 24 | $45.3M | $4.5M |
| Q4 25 | $72.1M | $1.9B | ||
| Q3 25 | $72.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $72.3M | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $477.3M | $1.5B | ||
| Q3 25 | $431.2M | $1.5B | ||
| Q2 25 | $398.3M | $1.5B | ||
| Q1 25 | $373.4M | $1.4B | ||
| Q4 24 | $349.0M | $1.4B | ||
| Q3 24 | $231.9M | $1.3B | ||
| Q2 24 | $188.3M | $1.3B | ||
| Q1 24 | $153.7M | $1.2B |
| Q4 25 | $624.2M | $5.1B | ||
| Q3 25 | $568.7M | $5.0B | ||
| Q2 25 | $558.4M | $4.8B | ||
| Q1 25 | $510.6M | $4.7B | ||
| Q4 24 | $488.7M | $4.7B | ||
| Q3 24 | $390.6M | $4.6B | ||
| Q2 24 | $376.4M | $4.4B | ||
| Q1 24 | $350.9M | $4.4B |
| Q4 25 | 0.15× | 1.23× | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | 1.26× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.6M | $63.5M |
| Free Cash FlowOCF − Capex | $34.6M | — |
| FCF MarginFCF / Revenue | 24.8% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | 0.72× | 3.92× |
| TTM Free Cash FlowTrailing 4 quarters | $27.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.6M | $63.5M | ||
| Q3 25 | $13.3M | $77.3M | ||
| Q2 25 | $21.1M | $60.8M | ||
| Q1 25 | $-19.7M | $43.2M | ||
| Q4 24 | $50.2M | $41.5M | ||
| Q3 24 | $25.0M | $53.5M | ||
| Q2 24 | $45.6M | $49.3M | ||
| Q1 24 | $-2.2M | $51.2M |
| Q4 25 | $34.6M | — | ||
| Q3 25 | $-1.1M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $-24.4M | — | ||
| Q4 24 | $47.5M | — | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $43.6M | — | ||
| Q1 24 | $-4.6M | — |
| Q4 25 | 24.8% | — | ||
| Q3 25 | -0.8% | — | ||
| Q2 25 | 15.3% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | 40.4% | — | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | -5.6% | — |
| Q4 25 | 0.8% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.9% | — |
| Q4 25 | 0.72× | 3.92× | ||
| Q3 25 | 0.36× | 1.71× | ||
| Q2 25 | 0.62× | 2.47× | ||
| Q1 25 | -0.73× | 2.61× | ||
| Q4 24 | 0.45× | 1.81× | ||
| Q3 24 | 0.70× | 1.39× | ||
| Q2 24 | 1.42× | 2.38× | ||
| Q1 24 | -0.12× | 4.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
HTO
| Water Utility Services | $191.0M | 96% |
| Other | $8.4M | 4% |
